Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
1601por Murase, Junya, Kubo, Shoji, Nishiguchi, Shuhei, Hirohashi, Kazuhiro, Shuto, Taichi, Ikebe, Takashi, Kinoshita, Hiroaki“…One hundred and forty‐seven patients with both anti‐hepatitis C virus antibody and hepatitis C virus RNA in their sera underwent curative resection for hepatocellular carcinoma in our department between 1991 and 1997. …”
Publicado 1999
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1602por Hainsworth, Samuel W., Dietze, Paul M., Wilson, David P., Sutton, Brett, Hellard, Margaret E., Scott, Nick“…BACKGROUND: Poor access to health services is a significant barrier to achieving the World Health Organization’s hepatitis C virus (HCV) elimination targets. We demonstrate how geospatial analysis can be performed with commonly available data to identify areas with the greatest unmet demand for HCV services. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1603“…Hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is associated with increased liver-related morbidity and mortality rates, accelerated progression to end-stage renal disease, and risk of cardiovascular events. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1604por Behzadifar, Masoud, Gorji, Hasan Abolghasem, Rezapour, Aziz, Bragazzi, Nicola Luigi, Alavian, Seyed Moayed“…The World Health Organization (WHO) has estimated that about 71 million people in the world have chronic hepatitis C virus (HCV) and 399,000 die every year due to cirrhosis and cancer caused by HCV. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1605por Ke, Ruian, Li, Hui, Wang, Shuyi, Ding, Wenge, Ribeiro, Ruy M., Giorgi, Elena E., Bhattacharya, Tanmoy, Barnard, Richard J. O., Hahn, Beatrice H., Shaw, George M., Perelson, Alan S.“…However, the molecular mechanisms that contribute to their rapid adaptation and persistence in vivo are not well studied. Here, we probe hepatitis C virus (HCV) persistence by analyzing clinical samples taken from subjects who were treated with a second-generation HCV protease inhibitor. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1606
-
1607“…Hepatitis C virus (HCV), the etiological agent of the most common and dangerous diseases of the liver, is a major health problem worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1608“…Methods: In a cohort of hepatitis C virus (HCV) infected patients undergoing liver transplantation, we observed differences in early viral infection kinetics of the allograft that associated with the time of liver transplant. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1609“…Chronic hepatitis C virus infection often leads to liver cirrhosis and primary liver cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1610por Soria, María Eugenia, Gregori, Josep, Chen, Qian, García-Cehic, Damir, Llorens, Meritxell, de Ávila, Ana I., Beach, Nathan M., Domingo, Esteban, Rodríguez-Frías, Francisco, Buti, María, Esteban, Rafael, Esteban, Juan Ignacio, Quer, Josep, Perales, Celia“…BACKGROUND: Despite the high sustained virological response rates achieved with current directly-acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 5–10% of treated patients do not respond to current antiviral therapies, and basal resistance to DAAs is increasingly detected among treatment-naïve infected individuals. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1611“…Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the HCV life cycle. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1612
-
1613por Kim, Nicole J., Magee, Catherine, Cummings, Cassie, Park, Helen, Khalili, Mandana“…Recent hepatitis C virus (HCV) guidelines recommend disease monitoring and hepatocellular carcinoma (HCC) screening in patients with advanced fibrosis after a sustained virologic response (SVR) with direct‐acting antiviral (DAA) therapy. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1614“…Treatment of hepatitis C virus (HCV) infection has evolved greatly through the recent decade. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1615por Cao, Huang, Zhao, Kaitao, Yao, Yongxuan, Guo, Jing, Gao, Xiaoxiao, Yang, Qi, Guo, Min, Zhu, Wandi, Wang, Yun, Wu, Chunchen, Chen, Jizheng, Zhou, Yuan, Hu, Xue, Lu, Mengji, Chen, Xinwen, Pei, Rongjuan“…The secondary structures of hepatitis C virus (HCV) RNA and the cellular proteins that bind to them are important for modulating both translation and RNA replication. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1616
-
1617por Stewart, Rachel A., MacDonald, Brooke R., Chu, Tzu-Chun, Moore, Jonathan D., Fasanmi, Esther O., Ojha, Rohit P.Enlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1618“…This scoring system is based on 10 donor factors including Hepatitis C virus (HCV) status from serological or NAT testing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1619
-
1620“…BACKGROUND: Hepatitis C (HCV) is a curable cause of liver disease, typically treated by specialists. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto